STOCK TITAN

SOLAI Financials

SLAI
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows SOLAI (SLAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLAI FY2025

Cost cutting and balance-sheet repair briefly improved optics, but cash burn still drives how this business operates.

FY2024’s $12.1M net income did not mark a real earnings turn because operating cash flow was still -$32.7M. FY2025 then reverted to a -$28.7M net loss while operating cash flow remained -$28.4M, showing weak cash conversion rather than a repaired core business, because operations still were not funding themselves.

Operating loss narrowed to -$8.0M from -$89.6M by FY2024. Because revenue over the same stretch fell to $32.9M from $57.0M, the cleaner income statement reflects cost retrenchment rather than demand-led operating leverage, with little sign that scale is covering fixed costs.

The balance-sheet posture improved as total liabilities fell to $19.6M from $47.5M. Even so, cash reserves were only $1.8M while operating cash flow stayed worse than -$28M, so balance-sheet cleanup has outpaced the rebuilding of liquid resources.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 18 / 100
Financial Health Score 18/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SOLAI's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
3
R&D Intensity
12
Revenue Progress
17
Burn Trend
46
Balance Sheet
28
Altman Z-Score Distress
-19.05

SOLAI scores -19.05, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($16.7M) relative to total liabilities ($10.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

SOLAI passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality
0.79x

For every $1 of reported earnings, SOLAI generates $0.79 in operating cash flow (-$26.9M OCF vs -$33.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$23.0M
YoY-30.1%
5Y CAGR+60.4%
10Y CAGR+4.1%

SOLAI generated $23.0M in revenue in fiscal year 2025. This represents a decrease of 30.1% from the prior year.

EBITDA
-$18.5M
YoY-624.2%

SOLAI's EBITDA was -$18.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 624.2% from the prior year.

Net Income
-$33.9M
YoY-380.6%

SOLAI reported -$33.9M in net income in fiscal year 2025. This represents a decrease of 380.6% from the prior year.

EPS (Diluted)
$-0.02
YoY-300.0%

SOLAI earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 300.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$27.1M
YoY+20.0%

SOLAI generated -$27.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 20.0% from the prior year.

Cash & Debt
$1.4M
YoY-21.5%
5Y CAGR-50.4%
10Y CAGR-31.0%

SOLAI held $1.4M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
1.87B

SOLAI had 1.87B shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
-46.9%
YoY-56.0pp
5Y CAGR-53.9pp

SOLAI's gross margin was -46.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 56.0 percentage points from the prior year.

Operating Margin
-150.9%
YoY-126.5pp
5Y CAGR+633.0pp
10Y CAGR+151.9pp

SOLAI's operating margin was -150.9% in fiscal year 2025, reflecting core business profitability. This is down 126.5 percentage points from the prior year.

Net Margin
-147.3%
YoY-184.0pp
5Y CAGR+1348.4pp
10Y CAGR+178.1pp

SOLAI's net profit margin was -147.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 184.0 percentage points from the prior year.

Return on Equity
-99.0%
YoY-120.2pp
5Y CAGR-46.5pp
10Y CAGR-80.6pp

SOLAI's ROE was -99.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 120.2 percentage points from the prior year.

Capital Allocation

R&D Spending
$874K
YoY+1166.7%
5Y CAGR-14.7%
10Y CAGR-21.4%

SOLAI invested $874K in research and development in fiscal year 2025. This represents an increase of 1166.7% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$220K
YoY-81.3%
5Y CAGR-0.4%
10Y CAGR-17.9%

SOLAI invested $220K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 81.3% from the prior year.

SLAI Income Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

SLAI Balance Sheet

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Total Assets $45.6M-34.0% $69.1M-20.0% $86.3M+36.4% $63.3M-12.8% $72.6M-11.6% $82.1M-5.4% $86.8M-63.6% $238.3M
Current Assets $17.7M+68.0% $10.5M-45.0% $19.1M-37.3% $30.5M-9.9% $33.9M-10.6% $37.9M+7.1% $35.3M-56.8% $81.7M
Cash & Equivalents $1.4M+15.9% $1.2M-32.3% $1.8M-21.2% $2.3M-29.2% $3.2M-28.9% $4.6M-17.0% $5.5M-75.6% $22.6M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $2.8M+90.7% $1.4M-21.6% $1.8M-39.9% $3.1M+6.7% $2.9M-30.4% $4.1M+15.5% $3.6M+185.5% $1.3M
Goodwill N/A N/A $0 N/A $0 N/A N/A $26.6M
Total Liabilities $10.9M-28.8% $15.3M-21.9% $19.6M+12.4% $17.4M-63.4% $47.5M+37.3% $34.6M+2.6% $33.7M-38.2% $54.5M
Current Liabilities $10.0M-11.6% $11.3M+0.9% $11.2M-28.0% $15.6M-65.2% $44.9M+39.4% $32.2M+4.5% $30.8M-39.4% $50.9M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $34.2M-21.9% $43.8M-23.0% $56.9M+24.0% $45.9M+82.6% $25.1M-47.2% $47.6M-10.4% $53.1M-70.2% $178.2M
Retained Earnings -$591.8M-3.5% -$571.8M-2.5% -$557.9M-1.2% -$551.0M+3.5% -$570.9M-4.2% -$548.0M-1.1% -$542.2M-32.6% -$408.9M

SLAI Cash Flow Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

SLAI Financial Ratios

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 1.76+0.8 0.93-0.8 1.70-0.3 1.95+1.2 0.75-0.4 1.17+0.0 1.15-0.5 1.60
Debt-to-Equity 0.32-0.0 0.350.0 0.34-0.0 0.38-1.5 1.89+1.2 0.73+0.1 0.63+0.3 0.31
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

SOLAI (SLAI) reported $23.0M in total revenue for fiscal year 2025. This represents a -30.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

SOLAI (SLAI) revenue declined by 30.1% year-over-year, from $32.9M to $23.0M in fiscal year 2025.

No, SOLAI (SLAI) reported a net income of -$33.9M in fiscal year 2025, with a net profit margin of -147.3%.

SOLAI (SLAI) reported diluted earnings per share of $-0.02 for fiscal year 2025. This represents a -300.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SOLAI (SLAI) had EBITDA of -$18.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

SOLAI (SLAI) had a gross margin of -46.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

SOLAI (SLAI) had an operating margin of -150.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

SOLAI (SLAI) had a net profit margin of -147.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

SOLAI (SLAI) has a return on equity of -99.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

SOLAI (SLAI) generated -$27.1M in free cash flow during fiscal year 2025. This represents a 20.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

SOLAI (SLAI) generated -$26.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

SOLAI (SLAI) had $45.6M in total assets as of fiscal year 2025, including both current and long-term assets.

SOLAI (SLAI) invested $220K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

SOLAI (SLAI) invested $874K in research and development during fiscal year 2025.

SOLAI (SLAI) had 1.87B shares outstanding as of fiscal year 2025.

SOLAI (SLAI) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.

SOLAI (SLAI) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

SOLAI (SLAI) had a return on assets of -74.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, SOLAI (SLAI) had $1.4M in cash against an annual operating cash burn of $26.9M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

SOLAI (SLAI) has an Altman Z-Score of -19.05, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

SOLAI (SLAI) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SOLAI (SLAI) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

SOLAI (SLAI) scores 18 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top